BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Pancreas
,
Holistic medicine
,
Fenofibrate
,
rs2230926
,
CYP51
,
Obesity
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Syk
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Macrophage of peripheral blood
Dendritic (plasmacytoid) cell
Bone marrow
Neutrophil of bone marrow
Myeloid cells of peripheral blood
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Multiple-resistant Staphylococcus aureus infection
Protozoan infection
Disease due to Orthopoxvirus
Caseating tuberculoid granuloma
Viremia
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Diazoxide
eticlopride
Bumetanide
fenspiride
anti-IgM
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
PRRT2
SMPDL3B
LDB1
RHOC
CASC8
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Spleen tyrosine kinase (SYK): an emerging target for the assemblage of small molecule antitumor agen…
Syk protein inhibitors treatment for the allergic symptoms associated with hyper immunoglobulin E sy…
Review and prospects of targeted therapies for Spleen tyrosine kinase (SYK).
New insights into SYK targeting in solid tumors.
Development of a time-resolved fluorescence resonance energy transfer ultra-high throughput screenin…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Predicting the Clinical Response to Omalizumab With Anti-Immunoglobulin E (IgE) Ab Response or Syk E…
Extension Study (Extended Access) of Syk-inhibition Using Fostamatinib to Treat Posttransplant Immun…
Study of Oral SKI-O-703, SYK Inhibitor, in Patients With Persistent and Chronic Immune Thrombocytope…
Treatment of Arthritis With Syk Kinase Inhibition (TASKI-1)
Azacitidine and Lintuzumab in Treating Patients With Previously Untreated Myelodysplastic Syndromes
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ